BioInvent Signs Clinical Trials Agreement with UK Cancer Charities
BioInvent International have announced that they have signed a clinical trial partnership with Cancer Research UK, Cancer Research Technology, and with Leukaemia and Lymphoma Research. The clinical trial partnership will assess BioInvent’s experimental antibody, BI-1206, in reducing resistance to rituximab treatment in patients with certain blood cancers.